January 2026 Global Health Intelligence Report: AI-Powered Analysis of 2.5 Million Blood Test Results Across 10 Countries

This technical report presents findings from AI-powered analysis of 2.5 million anonymized blood test results collected between January 2025 and January 2026 from users across 10 countries: United States, Germany, France, Italy, Spain, Portugal, Brazil, Netherlands, Belgium, and United Kingdom. Using Kantesti AI's proprietary 2.78 trillion parameter neural network with 98.7-99.84% clinical accuracy, the analysis reveals significant regional variations in chronic disease marker prevalence including cardiovascular disease (33.7%-44.8%), diabetes indicators (21.4%-34.2%), anemia (14.2%-31.5%), thyroid dysfunction (13.4%-19.8%), and vitamin D deficiency (14.8%-47.3%). Key findings include: highest cardiovascular markers in the United States (44.8%), highest anemia in Brazil (31.5%), highest vitamin D deficiency in Netherlands (47.3%), and elevated thyroid dysfunction in Germany (19.8%). Mediterranean countries demonstrated lower cardiovascular markers supporting dietary protective effects. Keywords: AI blood test analyzer, blood test interpretation, cardiovascular disease, diabetes biomarkers, anemia detection, thyroid dysfunction, metabolic syndrome, vitamin D deficiency, population health surveillance, neural network diagnostics